Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 18852689)

1.

Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.

Silverman GA, Luke CJ, Bhatia SR, Long OS, Vetica AC, Perlmutter DH, Pak SC.

Pediatr Res. 2009 Jan;65(1):10-8. doi: 10.1203/PDR.0b013e31819009b0. Review.

2.

Therapeutic target discovery using Caenorhabditis elegans.

Link EM, Hardiman G, Sluder AE, Johnson CD, Liu LX.

Pharmacogenomics. 2000 May;1(2):203-17. Review.

PMID:
11256592
3.

Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z.

Gosai SJ, Kwak JH, Luke CJ, Long OS, King DE, Kovatch KJ, Johnston PA, Shun TY, Lazo JS, Perlmutter DH, Silverman GA, Pak SC.

PLoS One. 2010 Nov 12;5(11):e15460. doi: 10.1371/journal.pone.0015460.

4.

Modeling human diseases in Caenorhabditis elegans.

Markaki M, Tavernarakis N.

Biotechnol J. 2010 Dec;5(12):1261-76. doi: 10.1002/biot.201000183. Epub 2010 Nov 29. Review.

PMID:
21154667
5.

Caenorhabditis elegans as a model system for triplet repeat diseases.

Voisine C, Hart AC.

Methods Mol Biol. 2004;277:141-60.

PMID:
15201454
6.

Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.

Dimitriadi M, Hart AC.

Neurobiol Dis. 2010 Oct;40(1):4-11. doi: 10.1016/j.nbd.2010.05.012. Epub 2010 May 19. Review.

8.

Functional characterisation of a cyst nematode acetylcholinesterase gene using Caenorhabditis elegans as a heterologous system.

Costa JC, Lilley CJ, Atkinson HJ, Urwin PE.

Int J Parasitol. 2009 Jun;39(7):849-58. doi: 10.1016/j.ijpara.2008.12.007.

PMID:
19367833
9.

Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.

Nass R, Merchant KM, Ryan T.

Mol Interv. 2008 Dec;8(6):284-93. doi: 10.1124/mi.8.6.6. Review.

PMID:
19144901
10.
11.

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Calahorro F, Ruiz-Rubio M.

Invert Neurosci. 2011 Dec;11(2):73-83. doi: 10.1007/s10158-011-0126-1. Epub 2011 Nov 8. Review.

PMID:
22068627
12.
13.

Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, Meyer JN.

Toxicol Sci. 2008 Nov;106(1):5-28. doi: 10.1093/toxsci/kfn121. Epub 2008 Jun 19. Review.

15.

High-throughput screening and biosensing with fluorescent C. elegans strains.

Leung CK, Deonarine A, Strange K, Choe KP.

J Vis Exp. 2011 May 19;(51). pii: 2745. doi: 10.3791/2745.

16.
17.

Caenorhabditis elegans as a model for lysosomal storage disorders.

de Voer G, Peters D, Taschner PE.

Biochim Biophys Acta. 2008 Jul-Aug;1782(7-8):433-46. doi: 10.1016/j.bbadis.2008.04.003. Epub 2008 May 1. Review.

18.

The Caenorhabditis elegans ing-3 gene regulates ionizing radiation-induced germ-cell apoptosis in a p53-associated pathway.

Luo J, Shah S, Riabowol K, Mains PE.

Genetics. 2009 Feb;181(2):473-82. doi: 10.1534/genetics.107.080515. Epub 2008 Nov 17.

19.

Gene-environment and protein-degradation signatures characterize genomic and phenotypic diversity in wild Caenorhabditis elegans populations.

Volkers RJ, Snoek LB, Hubar CJ, Coopman R, Chen W, Yang W, Sterken MG, Schulenburg H, Braeckman BP, Kammenga JE.

BMC Biol. 2013 Aug 19;11:93. doi: 10.1186/1741-7007-11-93.

20.

Genomic characterization of Tv-ant-1, a Caenorhabditis elegans tag-61 homologue from the parasitic nematode Trichostrongylus vitrinus.

Hu M, Campbell BE, Pellegrino M, Loukas A, Beveridge I, Ranganathan S, Gasser RB.

Gene. 2007 Aug 1;397(1-2):12-25. Epub 2007 Mar 30.

PMID:
17512141
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk